Oncology Institute Inc (NASDAQ:TOI) has a beta value of -61.20% and has seen 1.54 shares traded in the last trading session. The company, currently valued at $219.67M, closed the last trade at $2.38 per share which meant it lost -$4.62 on the day or 2.39% during that session. The TOI stock price is -47.06% off its 52-week high price of $3.50 and 94.54% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.49 million shares traded. The 3-month trading volume is 1.54 shares.
The consensus among analysts is that Oncology Institute Inc (TOI) is Buy stock at the moment, with a recommendation rating of 41.01. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Oncology Institute Inc (NASDAQ:TOI) trade information
Sporting 2.39% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TOI stock price touched $2.38 or saw a rise of 9.51%. Year-to-date, Oncology Institute Inc shares have moved 427.36%, while the 5-day performance has seen it change -9.81%. Over the past 30 days, the shares of Oncology Institute Inc (NASDAQ:TOI) have changed -14.03%. Short interest in the company has seen 1.56 million shares shorted with days to cover at 0.93.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 70.25% from current levels. The projected low price target is $6.0 while the price target rests at a high of $10.0. In that case, then, we find that the current price level is -320.17% off the targeted high while a plunge would see the stock gain -152.1% from current levels.
Oncology Institute Inc (TOI) estimates and forecasts
The company’s shares have gained 1114.43% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -62.37% -488.57% over the past 5 years.
TOI Dividends
Oncology Institute Inc is expected to release its next earnings report on 2024-Aug-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
Insiders own 14.24% of the company shares, while shares held by institutions stand at 34.67% with a share float percentage of 40.42%. Investors are also buoyed by the number of investors in a company, with Oncology Institute Inc having a total of 52.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 4.75 million shares worth more than $2.19 million. As of 2024-06-30, FMR LLC held 6.4005% of shares outstanding.
The other major institutional holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), with the holding of over 3.36 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.55 million and represent 4.5263% of shares outstanding.
